Financial results - KEMAPHARM S.R.L.

Financial Summary - Kemapharm S.r.l.
Unique identification code: 25324487
Registration number: J34/171/2009
Nace: 4773
Sales - Ron
289.797
Net Profit - Ron
11.844
Employees
7
Open Account
Company Kemapharm S.r.l. with Fiscal Code 25324487 recorded a turnover of 2024 of 289.797, with a net profit of 11.844 and having an average number of employees of 7. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Kemapharm S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 312.232 313.185 310.523 270.165 208.484 213.763 195.635 201.271 241.907 289.797
Total Income - EUR 313.516 313.362 310.703 270.166 209.560 228.277 195.636 206.384 241.908 290.327
Total Expenses - EUR 290.956 299.307 289.118 263.049 202.921 208.626 184.117 213.436 222.127 275.695
Gross Profit/Loss - EUR 22.561 14.055 21.584 7.117 6.638 19.651 11.519 -7.053 19.781 14.631
Net Profit/Loss - EUR 18.487 11.288 17.381 4.397 4.500 17.642 9.849 -8.866 17.327 11.844
Employees 7 7 8 9 7 7 7 7 7 7
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 20.5%, from 241.907 euro in the year 2023, to 289.797 euro in 2024. The Net Profit decreased by -5.386 euro, from 17.327 euro in 2023, to 11.844 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Kemapharm S.r.l.

Rating financiar

Financial Rating -
KEMAPHARM S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Kemapharm S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Kemapharm S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Kemapharm S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Kemapharm S.r.l. - CUI 25324487

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 8.094 6.859 5.524 21.638 16.110 30.423 23.718 2.751 1.960 1.386
Current Assets 158.421 100.436 111.772 78.879 78.781 91.968 81.912 86.003 122.321 144.128
Inventories 45.540 45.844 41.325 32.179 42.129 54.058 43.534 44.886 73.768 81.921
Receivables 90.532 27.751 69.676 45.464 36.170 37.788 38.233 40.513 40.239 44.338
Cash 22.350 26.842 771 1.236 481 122 145 604 8.315 17.869
Shareholders Funds 67.450 15.701 19.681 10.823 15.113 32.469 41.597 32.860 35.936 47.580
Social Capital 90 89 88 86 84 83 81 81 81 80
Debts 99.065 91.595 97.615 89.694 79.778 89.922 64.033 55.895 88.346 98.672
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 144.128 euro in 2024 which includes Inventories of 81.921 euro, Receivables of 44.338 euro and cash availability of 17.869 euro.
The company's Equity was valued at 47.580 euro, while total Liabilities amounted to 98.672 euro. Equity increased by 11.845 euro, from 35.936 euro in 2023, to 47.580 in 2024.

Risk Reports Prices

Reviews - Kemapharm S.r.l.

Comments - Kemapharm S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.